0001741830-23-000036.txt : 20230530 0001741830-23-000036.hdr.sgml : 20230530 20230530163612 ACCESSION NUMBER: 0001741830-23-000036 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230420 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20230530 DATE AS OF CHANGE: 20230530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kronos Bio, Inc. CENTRAL INDEX KEY: 0001741830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39592 FILM NUMBER: 23977050 BUSINESS ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (650) 781-5200 MAIL ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 8-K/A 1 kron-20230420.htm 8-K/A kron-20230420
0001741830FALSE00017418302023-04-202023-04-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K/A
Amendment No.1

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 20, 2023
Kronos Bio, Inc.
(Exact name of registrant as specified in its charter)
Delaware001-3959282-1895605
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
1300 So. El Camino Real, Suite 400
San Mateo, California 94402
(Address of principal executive offices including zip code)
Registrant’s telephone number, including area code: (650) 781-5200
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.001 par value per shareKRONThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Explanatory Note

As previously reported in our Current Report on Form 8-K filed with the Securities and Exchange Commission on April 24, 2023 (the “Initial Form 8-K”), on April 20, 2023, we appointed Roger Dansey, M.D. to our Board of Directors (the “Board”). Dr. Dansey’s potential Board committee appointments had not been established at the time of the Initial Form 8-K. Dr. Dansey’s Board committee appointment has now been determined, and accordingly we are amending the Initial Form 8-K to include that information.

In accordance with Rule 12b-15 of the Securities Exchange Act of 1934, as amended, the complete text of Item 5.02 of the Initial Form 8‑K, as amended hereby, is set forth below.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)

On April 20, 2023, we appointed Roger Dansey, M.D. to our Board of Directors (the “Board”) as a Class I director with a term ending at our annual meeting of stockholders to be held in 2024. On May 26, 2023, Dr. Dansey was appointed as a member of the Nominating and Corporate Governance Committee of the Board.

In accordance with our non-employee director compensation policy, Dr. Dansey received an initial option grant to purchase 68,000 shares of our common stock. The option vests in a series of three annual installments over the three-year period measured from the date of grant. Dr. Dansey is also eligible to receive an annual retainer of $40,000 for his service on the Board, an additional annual retainer of $4,000 for his service on the Nominating and Corporate Governance Committee of the Board, and an annual option grant on the date of each of our annual stockholder meetings. Dr. Dansey’s annual option grant at our 2023 annual meeting of stockholders will be prorated in accordance with our non-employee director compensation policy.

We have also entered into our standard form of indemnity agreement for directors and officers with Dr. Dansey.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
KRONOS BIO, INC.
Dated: May 30, 2023By:/s/ Norbert Bischofberger
Norbert Bischofberger, Ph.D.
President and Chief Executive Officer

EX-101.SCH 2 kron-20230420.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 kron-20230420_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 kron-20230420_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Period End Date Document Period End Date Entity Central Index Key Entity Central Index Key Document Information [Table] Document Information [Table] Entity Ex Transition Period Entity Ex Transition Period Entity Emerging Growth Company Entity Emerging Growth Company Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name Written Communications Written Communications Local Phone Number Local Phone Number Soliciting Material Soliciting Material Entity Address, State or Province Entity Address, State or Province City Area Code City Area Code Document Type Document Type Document Information [Line Items] Document Information [Line Items] Cover [Abstract] Entity Address, City or Town Entity Address, City or Town Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Amendment Flag Amendment Flag Trading Symbol Trading Symbol Entity Tax Identification Number Entity Tax Identification Number EX-101.PRE 5 kron-20230420_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page
Apr. 20, 2023
Cover [Abstract]  
Document Type 8-K/A
Document Period End Date Apr. 20, 2023
Entity Registrant Name Kronos Bio, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39592
Entity Tax Identification Number 82-1895605
Entity Address, Address Line One 1300 So. El Camino Real
Entity Address, Address Line Two Suite 400
Entity Address, City or Town San Mateo
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94402
City Area Code 650
Local Phone Number 781-5200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol KRON
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001741830
Amendment Flag false
Document Information [Line Items]  
Entity Emerging Growth Company false
XML 7 kron-20230420_htm.xml IDEA: XBRL DOCUMENT 0001741830 2023-04-20 2023-04-20 0001741830 false 8-K/A 2023-04-20 Kronos Bio, Inc. DE 001-39592 82-1895605 1300 So. El Camino Real Suite 400 San Mateo CA 94402 650 781-5200 false false false false Common Stock, $0.001 par value per share KRON NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.kronosbio.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports kron-20230420.htm kron-20230420.xsd kron-20230420_def.xml kron-20230420_lab.xml kron-20230420_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kron-20230420.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021q4": 23 }, "contextCount": 1, "dts": { "definitionLink": { "local": [ "kron-20230420_def.xml" ] }, "inline": { "local": [ "kron-20230420.htm" ] }, "labelLink": { "local": [ "kron-20230420_lab.xml" ] }, "presentationLink": { "local": [ "kron-20230420_pre.xml" ] }, "schema": { "local": [ "kron-20230420.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 27, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "kron", "nsuri": "http://www.kronosbio.com/20230420", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kron-20230420.htm", "contextRef": "ia5b2c3376171436e8ce8d50039c14002_D20230420-20230420", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.kronosbio.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kron-20230420.htm", "contextRef": "ia5b2c3376171436e8ce8d50039c14002_D20230420-20230420", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kronosbio.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001741830-23-000036-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001741830-23-000036-xbrl.zip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